Comprehensive genomic profiling for non-small-cell lung cancer: health and budget impact von Johnston, K M, Sheffield, B S, Yip, S, Lakzadeh, P, Qian, C, Nam, J

Volltext

PPM4 COMPREHENSIVE GENOMIC PROFILING FOR NON-SMALL CELL LUNG CANCER (NSCLC): A HEALTH AND BUDGET IMPACT ANALYSIS von Nam, J., Johnston, K., Yip, S., Qian, C., Lakzadeh, P., Sheffield, B.

Volltext

PPM5 COSTS OF IN-HOUSE MUTATIONAL-TESTING AND IMPLICATIONS FOR ECONOMIC EVALUATION: A CASE EXAMPLE OF NON-SMALL CELL LUNG CANCER (NSCLC) von Nam, J., Lakzadeh, P., Johnston, K., Yip, S., Qian, C., Sheffield, B.

Volltext

PSS5 THE COST-EFFECTIVENESS OF HALOBETASOL PROPIONATE (0.01%) AND TAZAROTENE (0.045%) FIXED COMBINATION RELATIVE TO OTHER TOPICAL THERAPIES IN MODERATE-TO-SEVERE PLAQUE PSORIASIS:... von Lakzadeh, P., Lozano-Ortega, G., Gaudet, V., Johnston, K., Barbeau, M.

Volltext

PCV64 - THE DIRECT RESOURCE USE AND MEDICAL COSTS OF HEART FAILURE IN NOVA SCOTIA, CANADA von Levy, A., Johnston, K., Daoust, A., Ignaszewski, A., Rogula, B., Lakzadeh, P., Fortier, J., Oh, P.

Volltext

Comprehensive Genomic Profiling for Non-Small-Cell Lung Cancer: Health and Budget Impact von Johnston, K M, Sheffield, B S, Yip, S, Lakzadeh, P, Qian, C, Nam, J

Volltext